The role of the preoperative serum carcinoembryonic antigen level in early-stage adenocarcinoma of the uterine cervix

Gynecologic Oncology

Volumn 94, Issue 2, 2004, Pages 363-367

  Tsai, Ching Chou ^a   Lin, Hao ^a   Huang, Eng Yen ^a   Huang, Shun Chen ^a   Hsieh, Chin Hsiung ^a   Chang, Shiuh Young ^a   Chien, Chan Chao Chang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

CEA; Cervical adenocarcinoma; Radical hysterectomy

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN;

AGE DISTRIBUTION; ANTIGEN DETECTION; CANCER GRADING; CANCER INVASION; CANCER SURGERY; CHI SQUARE DISTRIBUTION; CLINICAL FEATURE; DISEASE MARKER; EARLY CANCER; ENDOMETRIUM CARCINOMA; EVALUATION; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW;

EID: 3543090953     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.001     Document Type: Article

References (35)

1. Kjorstad K.E. Adenocarcinoma of the uterine cervix. Gynecol. Oncol. 5:1977;219-223
2. Hopkins M.P., Morley G.W. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet. Gynecol. 77:1991;912-917
3. Eifel P.J., Morris M., Oswald M.J., Wharton J.T., Delcols L. Adenocarcinoma of the uterine cervix: prognosis and patterns of failure in 367 cases. Cancer. 65:1990;2507-2514
4. Lai C.H., Hong J.H., Hsueh S., Ng K.K., Chang T.C., Tseng C.J. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer. 85:1999;1537-1546
5. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol. Oncol. 38:1990;352-357
6. Bloss J.D., Berman M.L., Mukhererjee J., Manetta A., Emma D., Ramsanghani N.S., et al. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecol. Oncol. 47:1992;21-27
7. Sevin B.U., Lu Y., Bloch D.A., Nadji M., Koechli O.R., Averette H.E. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer. 78:1996;1438-1446
8. Kaku T., Kamura T., Sakai K., Amada S., Kobayashi H., Shigematsu T., et al. Early adenocarcinoma of the uterine cervix. Gynecol. Oncol. 65(2):1997 May;281-285
9. Barber B.R., Sommers S.C., Rotterdam H., Kwon T. Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstet. Gynecol. 52:1978;343-348
10. Boyce J.G., Fruchter R.G., Nicastri A.D., DeRegt R.H., Ambiavagar P.C., Reinis M., et al. Vascular invasion in stage I carcinoma of the cervix. Cancer. 53:1984;1175-1180
11. Aoki Y., Sasaki M., Watanabe M., Sato T., Tsuneki I., Aida H., et al. High-risk group in node-positive patients with stage IB, IIA and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol. Oncol. 77:2000;305-309
12. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K., et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186
13. Stock R.G., Chen A.S., Flickinger J.C., Kalnicki S., Seski J. Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;31-36
14. Fuller A.F. Jr., Elliott N., Kosloff C., Hoskins W.J., Lewis J.L. Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol. Oncol. 33:1989;34-39
15. Hopkins M.P., Morley G.W. Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. Am. J. Obstet. Gynecol. 164:1991;1520-1527
16. de Bruijn H.W., Duk J.M., van der Zee A.G., Pras E., Willemse P.H., Boonstra H., et al. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumor Biol. 19:1998;505-516
17. Cooper B.C., Sood A.K., Davis C.S., Ritchie J.M., Sorosky J.I., Anderson B., et al. Preoperative CA125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstet. Gynecol. 100:2002;59-64
18. Ngan H.Y.S., Cheung A.N.Y., Lauder I.J., Wong L.C., Ma H.K. Prognostic significance of serum tumor markers in carcinoma of the cervix. Eur. J. Gynecol. Oncol. 17:1996;512-517
19. Leminen A. Tumor markers CA125, carcinoembryonic antigen and tumor associated trypsin inhibitor in patients with cervical adenocarcinoma. Gynecol. Oncol. 39:1990;358-363
20. Borras G., Molina R., Xercavins J., Ballesta A., Iglesias J. Tumor antigens CA19.9, CA125, and CEA in carcinoma of the uterine cervix. Gynecol. Oncol. 57:1995;205-211
21. Kurman RJ, Norris HJ, Wilkinson E. Tumors of the cervix, vagina and vulva. Atlas of tumor pathology. 3rd series, Book 4. Washington D.C.: Armed Forces Institute of Pathology (AFIP); 1992. p. 87.
22. Hurt W.G., Silverberg S.G., Frable W.J., Belgrad R., Crooks L.D. Adenocarcinoma of the cervix: histopathologic and clinical features. Am. J. Obstet. Gynecol. 129:1977;304-315
23. Konishi I., Fujii S., Nanbu Y., Nonogaki H., Mori T. Mucin leakage into the cervical stroma may increase lymph node metastasis in mucin-producing cervical adenocarcinomas. Cancer. 65:1990;229-237
24. Fuller A.F. Jr., Elliott N., Kosloff C., Hoskins W.J., Lewis J.L. Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol. Oncol. 33:1989;34-39
25. Hricak H., Lacey C.G., Sandles L.G., Chang Y.C., Winkler M.L., Stern J.L. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 166:1988;623-631
26. Follen M., Levenback C.F., Iyer R.B., Grigsby P.W., Boss E.A., Delpassand E.S., et al. Imaging in cervical cancer. Cancer. 98(9 Suppl.):2003;2028-2038
27. FIGO annual report on the results of treatment in gynecological cancer. Int. J. Gynecol. Obstet. 36:1991;39. (Supplement)
28. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.B., et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 76:1995;1948-1955
29. Smith H.O., Qualls C.R., Romero A.A., Webb J.C., Dorin M.H., Padilla L.A., et al. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynecol. Oncol. 85:2002;229-241
30. Shipman S.D., Bristow R.E. Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix. Curr. Opin. Oncol. 13:2001;394-398
31. Michalas S., Rodolakis A., Voulgaris Z., Vlachos G., Giannakoulis N., Diakomanolis E. Management of early-stage cervical carcinoma by modified (Type II) radical hysterectomy. Gynecol. Oncol. 85(3):2002 Jun;415-422
32. Sartori E., Fallo L., La Face B., Bianchi U.A., Pecorelli S. Extended radical hysterectomy in early-stage carcinoma of the uterine cervix: tailoring the radicality. Int. J. Gynecol. Cancer. 5(2):1995 Mar;143-147
33. Kennedy A.W., elTabbakh G.H., Biscotti C.V., Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol. Oncol. 58:1995;274-277
34. Duk J.M., De Bruijn H.W., Groenier K.H., Fleuren G.J., Aalders J.G. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics. Cancer. 65:1990;1830-1837
35. Kjorstad K.E., Orjasaeter H. The prognostic significance of carcinoembryonic antigen determinations in patients with adenocarcinoma of the cervix. Gynecol. Oncol. 19(3):1984 Nov;284-289